Skip to main content
Home

Top menu InfoLep

  • About InfoLep

Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2022
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Publications
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Search

Refine your results

Refine your results


Selected filters

  • Reset filters
  • 2021
  • 2019
  • South-East Asia Region (SEAR)
  • Immunoprophylaxis / Vaccine

Filter by type

  • Publications only

NTD

  • Leprosy (Hansen disease) (8)

Subject

  • (-) Immunoprophylaxis / Vaccine (8)
  • Contacts / Contact tracing (3)
  • Mycobacterium indicus pranii (MIP) (2)
  • Costs / Cost-effectiveness of interventions (1)
  • Preventive Chemotherapy (PC) (2)
  • Erythema nodosum leprosum - enl (Type 2 reaction) (1)
  • SDR-PEP (1)
  • Social Economic Rehabilitation (1)
  • Case detection (1)
  • Complications and reactions (1)
  • Uniform multi-drug therapy (U-MDT) (1)
  • Health systems factors (1)
  • Integrated approach (1)
  • Epidemiology (1)
  • Prevention of disease (3)
  • Diagnosis (1)
  • Management of disease complication (2)
  • Treatment (1)
  • Drug resistance (1)
  • Prevention of disability (pod) (1)
  • Self-care (1)
  • Rehabilitation (1)
  • Mental health (1)
  • Stigma (leprosy related) (1)
  • Discriminatory laws & Legislation (1)
  • Human rights (1)

Publication Type

  • Article (7)
  • Case study (1)
  • Full text online (6)
  • Global leprosy strategy (1)
  • Report (1)
  • WHO publication (1)

Journal

  • Anais brasileiros de dermatologia (1)
  • Community skin health (1)
  • Indian journal of dermatology, venereology and leprology (1)
  • International immunopharmacology (1)
  • Jurnal Berkala Epidemiologi (1)
  • The Indian journal of medical research (1)
  • Vaccine (1)

Year of Publication

  • (-) 2021 (5)
  • 2020 (8)
  • (-) 2019 (3)
  • 2018 (2)
  • 2017 (3)
  • 2016 (3)
  • 2015 (2)
  • 2012 (1)
  • 2009 (1)
  • 2005 (2)
  • 1999 (2)
  • 1998 (1)
  • 1995 (1)

Language

  • English (7)

Regional focus

  • African Region (AFR) (1)
  • Eastern Mediterranean Region (EMR) (1)
  • European Region (EUR) (1)
  • Region of the Americas (AMR) (1)
  • (-) South-East Asia Region (SEAR) (8)
    • Bangladesh (1)
    • India (5)
    • Indonesia (1)
  • Western Pacific Region (WPR) (1)
 
  • Relevance
  • Date
8 items

Publication

Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine.

Gupta S, Kumari S. Anais brasileiros de dermatologia. 2021;
Download PDF

Publication

Cost-effectiveness of incorporating vaccine to multidrug therapy in newly diagnosed leprosy cases for better treatment outcomes & immunoprophylaxis in contacts as leprosy control measures for National Leprosy Eradication Programme in India.

Muniyandi M, Singh M, Singh M, et al. The Indian journal of medical research. 2021; 154 (1) : 121-131.
Download PDF

Publication

BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease.

van Hooij A, van den Eeden S, Khatun M, et al. Vaccine. 2021;
Download PDF

Publication

Mycobacterium indicus pranii vaccine immunoprophylaxis in anti-phenolic glycolipid-1-positive leprosy contacts - A pilot study from a tertiary care center in North India.

Sendhil Kumaran M, Narang T, Chabbra S, et al. Indian journal of dermatology, venereology and leprology. 2021;
Download PDF

Publication

Towards zero leprosy. Global leprosy (‎Hansen’s Disease)‎ strategy 2021–2030

World Health Organization . 2021;
Download PDF

Publication

National leprosy symposium 2018

Community skin health. 2019;
Download PDF

Publication

The effect of contact history and immunization status on the case of leprosy

Nurzila U, Adriyani R. Jurnal Berkala Epidemiologi. 2019;
Download PDF

Publication

Cell wall fraction of Mycobacterium indicus pranii shows potential Th1 adjuvant activity.

Saqib M, Khatri R, Singh B, et al. International immunopharmacology. 2019;

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2022 InfoNTD